Drug Topics
MARCH 31, 2025
Jean-Venable Goode, BSPharm, PharmD, and Jeff Goad, PharmD, MPH, presented on the most notable vaccine updates from the past year and how they impact pharmacy practice.
STAT
MARCH 31, 2025
The forced resignation of Peter Marks , the Food and Drug Administration official in charge of regulating vaccines, gene therapies, and the blood supply, led to panic over the weekend in the worlds of public health and biopharmaceuticals — two worlds that often agree on very little aside from their belief in the safety and effectiveness of vaccines.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 27, 2025
Lauren Angelo, PharmD, MBA, discussed current vaccination sentiments across the country and how misinformation has contributed to declining rates among US patients.
STAT
MARCH 27, 2025
Both deputy directors at the key Food and Drug Administration center that oversees the regulation of cancer drugs plan on departing the agency, sources told STAT Thursday, highlighting the drain on talent at the FDA created by layoffs, uncertainty, and shifts in policy at the agency even as it is set to lay off thousands more people. Both Paul G. Kluetz, who joined the FDA as a medical reviewer in 2016, and Marc R.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaVoice
MARCH 31, 2025
The two market leaders are targeting new obesity alternatives in their pipelines with an eye toward a triple threat.
Hospital Pharmacy Europe
MARCH 31, 2025
Sustainability has become central to the mission of hospital pharmacists, who are uniquely positioned to minimise waste, reduce healthcares environmental footprint and enhance patient outcomes. In his latest commentary, Dr Joo Gonalves PhD explores how digital health tools, artificial intelligence and circular economy models can drive meaningful change in hospital pharmacy practice.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MARCH 27, 2025
WASHINGTON — Around 3,500 employees are on the chopping block at the Food and Drug Administration, but they don’t yet know who they are. The Health and Human Services Department on Thursday announced a sweeping plan to cut 10,000 jobs and consolidate operations across its sub-agencies. FDA drug, medical device, or food reviewers and inspectors will not be among those fired, according to an HHS fact sheet.
PharmaVoice
APRIL 1, 2025
The lack of clear communication from the government could spark wide-ranging issues in pharma — from sowing confusion about clinical trial design to further eroding public trust.
Pharma Marketing Network
MARCH 27, 2025
Introduction Social media advertising has undergone a major transformation in the pharmaceutical industry over the past decade. What once was a cautious, slow-moving experiment has now become a vital component of modern pharma marketing strategies. The increasing integration of platforms like LinkedIn, X (formerly Twitter), YouTube, and even TikTok has dramatically shifted how pharma brands engage with healthcare professionals (HCPs), patients, and caregivers.
Pharmafile
MARCH 28, 2025
The US Food and Drug Association (FDA) has granted fast track designation to Sanofis mRNA vaccine candidate for the prevention of chlamydia infection. The chlamydia vaccine candidate has been designed to protect against primary genital tract infection and reinfection caused by the bacterium Chlamydia trachomatis. Sanofi is an international pharma and healthcare company, providing vaccination […] The post FDA grants fast track designation to chlamydia vaccine candidate appeared first on Pha
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
MARCH 27, 2025
Tom DePietro, PharmD, owner of DePietro's Pharmacy, discusses how his pharmacy served their community during the COVID-19 pandemic.
STAT
MARCH 27, 2025
WASHINGTON — Sen. Bill Cassidy, the chairman of the Senate health committee, voted to confirm Robert F. Kennedy Jr. as the nation’s health secretary last month on the condition that Kennedy, a longtime vaccine critic, keep him apprised of agency actions, especially those related to vaccines. On Thursday morning, Cassidy said, the two had breakfast to discuss Kennedy’s plans to lay off 10,000 Health and Human Services Department employees.
PharmaVoice
MARCH 28, 2025
The agency is still unclear about where it will stand on clinical trial diversity, but companies are looking for answers and leaning toward good science.
Pharmacy Times
MARCH 30, 2025
The trial is the first to test the cardiovascular benefits of an oral glucagon-like peptide-1 (GLP-1) agonist.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Checkup by Singlecare
APRIL 1, 2025
Olanzapine (brand names Zyprexa or Zyprexa Zydis) is a second-generation antipsychotic medication that’s FDA approved to treat mental health conditions like schizophrenia and bipolar disorder, including mixed or manic episodes. It’s also approved for treatment-resistant depression or depression with bipolar I disorder in combination with fluoxetine.
Drug Topics
MARCH 27, 2025
Lindsey Miller, PharmD, clinical assistant professor of pharmacy practice at the University of Mississippi, discusses how pharmacists can help patients understand and effectively use continuous glucose monitoring.
STAT
MARCH 27, 2025
When I was secretary of the Department of Health and Human Services under President Bill Clinton, an agency head came to me with a dramatic reorganization plan. I advised him that unless it was data- and outcome-driven, he was wasting his time. Just as important, the reorganization would unsettle and confuse his new colleagues. As a result, his legacy would be a new structure rather than improving people’s lives.
PharmaVoice
MARCH 26, 2025
A delay of the prescription-to-OTC rule signals health agencies’ ongoing reluctance to implement new regulations.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmafile
MARCH 31, 2025
The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran) as the first therapy in the US to treat haemophilia A or B, with or without inhibitors. The approval of the antithrombin-lowering (AT) drug was based on data from the ATLAS phase 3 studies that Sanofi conducted. Sanofi is an international pharma and healthcare […] The post Qfitlia approved by FDA to treat haemophilia A or B appeared first on Pharmafile.
Fierce Healthcare
MARCH 26, 2025
The Centers for Disease Control and Prevention is reportedly rescinding $11.4 billion in funds to states, cities and organizations receiving grants for COVID-19 efforts.
Drug Topics
MARCH 28, 2025
Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.
DiversifyRx
MARCH 27, 2025
Dont Get Burned: What Every Pharmacy Owner Needs to Know About Diabetic Testing Supplies Lets talk about something thats come up in multiple conversations with pharmacy owners latelyand its a topic you cant afford to ignore: diabetic testing supplies. Whether youre billing Medicare, selling to cash patients, or stocking your shelves for convenience, diabetic testing supplies can be a reliable source of revenue.
Pharmacy Times
MARCH 31, 2025
A phase 1/2 clinical trial will provide crucial data on the vaccine's tolerability and pave the way for future development and potential widespread use.
Hospital Pharmacy Europe
APRIL 1, 2025
A new toolkit to support pharmacists when integrating artificial intelligence (AI) into daily practice has been launched by the International Pharmaceutical Federation (FIP). The toolkit for hospital, industry and community settings offers structured guidance on AI adoption. It covers ethical considerations, implementation strategies, regulatory compliance and real-world applications to help pharmacists optimise patient care, stimulate multidisciplinary interaction and enhance operational effici
Drug Topics
MARCH 26, 2025
Experts discuss what they learned at the American Pharmacists Association Annual Meeting and Exposition 2025.
STAT
APRIL 1, 2025
The CDC cuts announced Tuesday threaten America’s health, safety, and economy. Despite claims of efficiency, these cuts target proven programs that prevent disease and save lives — and as a result, Americans will be sicker and face increased health care costs. The government’s goal should not be to hit an arbitrary number of jobs eliminated, but to focus on the number of illnesses and premature deaths prevented.
The Checkup by Singlecare
MARCH 31, 2025
With the skyrocketing popularity of injectable medications Ozempic and Wegovy , a shortage inevitably followed. Ozempic and Wegovy (and Rybelsus , which is oral semaglutide) are GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists, commonly referred to as GLP-1s) and are the only FDA-approved drugs that contain the active ingredient semaglutide.
PharmaVoice
APRIL 1, 2025
Dr. Mikael Dolsten, Pfizer’s former chief scientific officer, is embarking on a journey of curiosity and interconnectedness in his post-Big Pharma career.
Pharma Marketing Network
MARCH 31, 2025
Introduction Pharmaceutical marketing is entering a new era in 2025, driven by rapid advancements in technology, evolving patient expectations, and tighter compliance demands. As industry leaders adapt to digital-first communication and omnichannel engagement, the need for smart, scalable, and strategic marketing tactics is more urgent than ever. Whether you’re launching a new branded drug or optimizing an established portfolio, staying ahead of the curve in pharmaceutical marketing has be
Drug Topics
MARCH 27, 2025
Luke Berenbrok, PharmD, MS, discussed pharmacy deserts and how closures around the US have the potential to impact public health.
STAT
MARCH 31, 2025
Heart disease has long been the leading killer of adults, but beyond that stark fact, men and women diverge. From differences at the cellular level of the heart to circulatory structure to symptoms of distress and treatment, researchers are finding new manifestations of gender differences in cardiovascular disease.
The Checkup by Singlecare
MARCH 31, 2025
Ozempic is the brand name for semaglutide, which is a medication thats FDA approved to treat high blood sugar in people with Type 2 diabetes. It is also often prescribed off-label as a weight loss medication, even in patients with normal blood sugars. Ozempic is a type of medication called a glucagon-like peptide-1 agonist (GLP-1) and is only given by injection.
PharmaVoice
MARCH 31, 2025
This technology brings both benefits and drawbacks for the field, which is also testing alternatives.
Expert insights. Personalized for you.
476 
Let's personalize your content